Furthermore, Rasmussen [27] and Niu [28] et al. have demonstrated that β3-AR agonists could improve cardiac function of HF patients and a lack of β3-AR could exacerbate LV dilation and dysfunction [29]. Here, ADRB3 is linked to hydrops fetalis.